This story originally ran on Dec. 7.
By Tony Fong
Nano-proteomics technology development firm Cell Biosciences today announced that it has acquired sample preparation firm Protein Forest for an undisclosed price in a deal designed to accelerate its growth in the proteomics space.
In connection with the all-stock transaction, Cell Biosciences said it raised an additional $4 million in equity financing. Novo A/S, an existing investor in the firm, led the financing round.